Mandawe, Liza .
HRN: 27-58-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 1.5GM (VIAL)
08/06/2025
08/13/2025
IV
1.5gm
Q8
Empiric
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: